CERTARA INC. - COMMON
10.99
07-November-24 15:59:58
15 minutes delayed
Stocks
+0.08
+0.73%
Today's range
10.08 - 11.02
ISIN
N/A
Source
NASDAQ
-
21 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
-
Certara Reports Third Quarter 2023 Financial Results
08 Nov 2023 16:10:01 By Nasdaq GlobeNewswire
-
11 Oct 2023 16:15:00 By Nasdaq GlobeNewswire
-
19 Sep 2023 08:15:00 By Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
29 Aug 2023 16:15:00 By Nasdaq GlobeNewswire
-
Certara Simcyp™ Group Awarded Two New Grants from US FDA
29 Aug 2023 08:15:00 By Nasdaq GlobeNewswire
-
Certara Reports Second Quarter 2023 Financial Results
09 Aug 2023 16:15:01 By Nasdaq GlobeNewswire
-
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
13 Jul 2023 16:30:00 By Nasdaq GlobeNewswire
-
Certara to Participate in the Jefferies Global Healthcare Conference
02 Jun 2023 16:15:00 By Nasdaq GlobeNewswire
-
Certara Reports First Quarter 2023 Financial Results
08 May 2023 16:15:00 By Nasdaq GlobeNewswire
-
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
27 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
10 Apr 2023 16:30:00 By Nasdaq GlobeNewswire
-
A.I. Coming to Certara’s D360 Scientific Informatics Software
09 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
07 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
01 Mar 2023 16:16:01 By Nasdaq GlobeNewswire
-
Certara Announces Transition Plan for Chief Financial Officer
01 Mar 2023 16:15:00 By Nasdaq GlobeNewswire
-
Certara to Participate in the Barclays Global Healthcare Conference
27 Feb 2023 16:30:00 By Nasdaq GlobeNewswire
-
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
01 Feb 2023 16:30:00 By Nasdaq GlobeNewswire
-
04 Jan 2023 07:31:24 By Nasdaq GlobeNewswire
-
08 Dec 2022 16:30:00 By Nasdaq GlobeNewswire